Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence-Reference-Cited by-同舟云学术

Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

Published:2016-05-22 Issue:5 Volume:22 Page:1366-1377
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Garcia-Marchena Nuria¹,Pavon Francisco J.¹,Pastor Antoni²³⁴,Araos Pedro¹,Pedraz Maria¹,Romero-Sanchiz Pablo¹,Calado Montserrat¹,Suarez Juan¹,Castilla-Ortega Estela¹,Orio Laura⁵,Boronat Anna²³⁴,Torrens Marta⁶⁷⁸,Rubio Gabriel⁹¹⁰,de la Torre Rafael²⁴¹¹,Rodriguez de Fonseca Fernando¹,Serrano Antonia¹

Affiliation:

1. Unidad de Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA); Hospital Regional Universitario de Málaga; Spain

2. Grup de Recerca en Farmacología Integrada i Neurociencia de Sistemes, Programa de Recerca en Neurociencia; IMIM (Hospital del Mar Medical Research Institute); Spain

3. Department de Farmacologia, Toxicologia i Terapeutica, Facultat de Medicina; Universitat Autonoma de Barcelona; Spain

4. CIBER Fisiopatologia Obesidad y Nutricion (CIBERObn); ISCIII; Spain

5. Departamento de Psicobiología, Facultad de Psicología; Universidad Complutense; Spain

6. Institut de Neuropsiquiatria i Adiccions (INAD) del Parc de Salut MAR; Spain

7. IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain

8. Department of Psychiatry; Univ Autonoma de Barcelona; Spain

9. Departamento de Psiquiatria, Facultad de Medicina; Universidad Complutense; Spain

10. Instituto de Investigación Hospital 12 de Octubre; Spain

11. Facultat de Ciencies de la Salut i de la Vida; Universidat Pompeu Fabra (CEXS-UPF); Spain

Funder

Ministerio de Economía y Competitividad and Instituto de Salud Carlos III

Instituto de Salud Carlos III and EU-ERDF

Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas

Junta de Andalucía, Plan Andaluz de Investigación, Desarrollo e Innovación

Junta de Andalucía-Consejería de Economía, Innovación y Ciencia

Junta de Andalucía-Consejería de Igualdad, Salud y Políticas Sociales

Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER/EU-ERDF)

ISC-III

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/adb.12408/fullpdf

Reference50 articles.

1. Activation of TRPV1 by the satiety factor oleoylethanolamide;Ahern;J Biol Chem,2003

2. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity;Araos;Addict Biol,2015

3. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells;Basavarajappa;J Neurochem,1999

4. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons;Basavarajappa;Eur J Pharmacol,2003

5. Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARalpha receptor-independent mechanism;Bilbao;Addict Biol,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conclusion;Anandamide in Health and Disease;2025

2. Anandamide signaling dysfunction in the development of alcohol use disorders;Anandamide in Health and Disease;2025

3. Anandamide and anxiety;Anandamide in Health and Disease;2025

4. The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder;Biological Psychiatry Global Open Science;2024-11

5. Region-Specific Gene Expression Changes Associated with Oleoylethanolamide-Induced Attenuation of Alcohol Self-Administration;International Journal of Molecular Sciences;2024-08-19